Lista de obras -

18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results

artículo científico publicado en 2010

A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities

artículo científico publicado en 2015

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).

artículo científico publicado en 2008

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

artículo científico publicado en 2015

A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).

artículo científico publicado en 2017

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

artículo científico publicado en 2015

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS): Table 6:

article

A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer

scientific article published on 14 April 2020

Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way ⬇️

artículo científico publicado el 15 de enero de 1993

Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency

artículo científico publicado en 2008

An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy

artículo científico publicado en 2011

Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer

scientific article published on 06 September 2018

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco

artículo científico publicado en 2013

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?

artículo científico publicado en 2012

Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study

scientific article published on 31 January 2017

Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor

artículo científico publicado en 2020

Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib ⬇️

artículo científico publicado el 8 de marzo de 2013

Concurrent radiotherapy and panitumumab after lymph node dissection and induction chemotherapy for invasive bladder cancer

artículo científico publicado en 2019

Determination of glycosuria using o-toludine-glacial acetic acid

artículo científico publicado el 24 de junio de 1970

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

artículo científico publicado en 2014

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers

artículo científico publicado en 2016

Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b.

artículo científico publicado en 2005

FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer

artículo científico publicado en 2012

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

scholarly article by Arnon P Kater et al published January 2019 in Haematologica

Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils ⬇️

artículo científico publicado el 1 de diciembre de 1994

Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells ⬇️

artículo científico publicado el 15 de marzo de 1993

Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients

artículo científico publicado en 2016

Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.

artículo científico publicado en 2015

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

artículo científico publicado en 2014

Induction chemotherapy followed by surgery in node positive bladder cancer

artículo científico publicado en 2013

Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management

artículo científico publicado en 2011

Interleukin-6 is a survival factor for committed myeloid progenitor cells

artículo científico publicado el 1 de noviembre de 1993

Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder ⬇️

artículo científico publicado el 11 de diciembre de 2012

Local production of interleukin-6 during acute rejection in human renal allografts

artículo científico publicado en 1993

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.

artículo científico publicado en 2014

Neoadjuvant chemotherapy in advanced penile carcinoma

scientific article published on 14 February 2007

Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin

artículo científico publicado en 2015

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients

artículo científico publicado en 2005

Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone

artículo científico publicado en 2014

Platelet volume analysis in thrombocytopenia in relation to bleeding tendency.

artículo científico publicado en 1986

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy; results from the HOVON 109 study

artículo científico publicado en 2020

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

artículo científico publicado en 2009

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

artículo científico publicado en 2011

Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells ⬇️

artículo científico publicado el 1 de diciembre de 1993

Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al

artículo científico publicado en 2016

Reply to the letter to the editor ‘The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice’ by Hartmann and the letter ‘Comment on ESMO Magnitude of Clinical Benefit Scale’ by Muhonen et al

artículo científico publicado en 2015

Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience

artículo científico publicado en 2013

Risk of diabetes after para-aortic radiation for testicular cancer

artículo científico publicado en 2018

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy

artículo científico publicado en 2009

Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic disease

scientific article published on 28 March 2019

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients

scientific article published on 02 June 2019

Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review.

artículo científico publicado en 2010

Lista de obras de

18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results

A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS): Table 6:

A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer

Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way ⬇️

Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency

An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy

Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?

Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study

Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor

Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib ⬇️

Concurrent radiotherapy and panitumumab after lymph node dissection and induction chemotherapy for invasive bladder cancer

Determination of glycosuria using o-toludine-glacial acetic acid

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers

Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b.

FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils ⬇️

Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells ⬇️

Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients

Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Induction chemotherapy followed by surgery in node positive bladder cancer

Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management

Interleukin-6 is a survival factor for committed myeloid progenitor cells

Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder ⬇️

Local production of interleukin-6 during acute rejection in human renal allografts

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.

Neoadjuvant chemotherapy in advanced penile carcinoma

Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients

Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone

Platelet volume analysis in thrombocytopenia in relation to bleeding tendency.

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy; results from the HOVON 109 study

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells ⬇️

Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al

Reply to the letter to the editor ‘The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice’ by Hartmann and the letter ‘Comment on ESMO Magnitude of Clinical Benefit Scale’ by Muhonen et al

Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience

Risk of diabetes after para-aortic radiation for testicular cancer

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy

Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic disease

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients

Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review.

[Network of specialized sarcoma centres]